This analysis uncovers payment patterns to health care professionals and teaching hospitals by AI medical device manufacturers, suggesting transparency is needed.
This study examines the extent and nature of payments made to health care professionals and teaching hospitals by manufacturers of FDA-authorized AI- and machine learning–enabled devices.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: